期刊文献+

基于癌基因组图谱挖掘胃癌预后相关基因 被引量:2

Identification of genes associated with gastric cancer prognosis from TCGA datasets
下载PDF
导出
摘要 目的利用癌基因组图谱数据库中的大量胃癌基因组数据,在高频突变或肿瘤组织高表达的基因中挖掘与临床分化和预后相关的基因。方法从癌基因组图谱数据集中下载胃癌基因组的突变数据,基因表达数据以及病例样本的临床信息资料。筛选并统计出现有害突变频率较高的基因,并比较这些基因在不同分化程度病例中的突变次数。同时利用DESeq2对基因表达数据进行差异表达分析,对于在肿瘤组织中高表达的基因做生存分析,使用Log-rank检验并做FDR校正,筛选出mRNA表达量与胃癌预后相关联的基因。结果突变分析得到PIK3CA和APC的有害突变频率在不同分化程度的胃癌存在差异(Fisher's exact test:P<0.05)。差异表达分析得到2 040个在肿瘤组织中上调的基因,2 357个在肿瘤组织中下调的基因。生存分析得到8个对胃癌预后有影响的基因,1个为保护因素,7个危险因素。结论本研究通过挖掘癌基因组图谱中的胃癌数据集,得到了ANGPT2、MMP10和WISP3等与胃癌分化及预后相关的基因,为接下来的研究提供了线索和依据,也为临床治疗提示了新的预后指标。 Objective To identify genes associated with prognosis or differentiated type in gastric cancer from fre- quently mutated genes or highly-expressed genes, using large-scale genomic data from The Cancer Genome Atlas. Methods The somatic mutation data, RNAseqV2 data and clinical information were downloaded from the TCGA website. The frequency of deleterious somatic mutations for each gene was counted to select the frequently mutated genes. DESeq2 was used to analyze the gene expression data. Then survival analysis was performed on genes highly- expressed in the tumor tissue. Kaplan-Meier curves were generated by R-survival package, and significance was e- valuated by log-rank test. Results The frequency for pathogenic mutations in PIK3CA and APC was significantly discordant between different grades of gastric cancer. 2 040 genes were up-regulated in tumor tissue, while 2 357 genes were down-regulated. Among the up-regulated genes, 7 genes were associated with poor prognosis of gastric cancer and one was associated with better prognosis. Conclusions Genes associated with differentiation types or prognosis in gastric cancer are identified. The result may clue us future research on potential prognostic markers in clinical treatment.
出处 《基础医学与临床》 CSCD 2017年第7期1042-1046,共5页 Basic and Clinical Medicine
关键词 癌症基因组图谱 体细胞突变 表达量 预后 the cancer genome atlas somatic mutation gene expression prognosis
  • 相关文献

参考文献1

  • 1Michele Orditura,Gennaro Galizia,Vincenzo Sforza,Valentina Gambardella,Alessio Fabozzi,Maria Maddalena Laterza,Francesca Andreozzi,Jole Ventriglia,Beatrice Savastano,Andrea Mabilia,Eva Lieto,Fortunato Ciardiello,Ferdinando De Vita.Treatment of gastric cancer[J].World Journal of Gastroenterology,2014,20(7):1635-1649. 被引量:125

二级参考文献11

  • 1Muhammed Ashraf Memon,Nick Butler,Breda Memon.The issue of lymphadenectomy during laparoscopic gastrectomy for gastric carcinoma[J].World Journal of Gastrointestinal Oncology,2010,2(2):65-67. 被引量:10
  • 2Wei-guo Zhu,Da-fu Xua,Jun Pu,Cheng-dong Zong,Tao Li,Guang-zhou Tao,Fu-zhi Ji,Xi-lei Zhou,Ji-hua Han,Cheng-shi Wang,Chang-hua Yu,Jiang-guo Yi,Xi-long Su,Jin-xia Ding.A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection[J]. Radiotherapy and Oncology . 2012 (3)
  • 3Mun Ki Choi,Gwang Ha Kim,Do Youn Park,Geun Am Song,Dong Uk Kim,Dong Yup Ryu,Bong Eun Lee,Jae Hoon Cheong,Mong Cho.Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a single-center experience[J]. Surgical Endoscopy . 2013 (11)
  • 4Andrea Coratti,Mario Annecchiarico,Michele Di Marino,Edoardo Gentile,Francesco Coratti,Pier Cristoforo Giulianotti.Robot-assisted Gastrectomy for Gastric Cancer: Current Status and Technical Considerations[J].World Journal of Surgery.2013(12)
  • 5Benjamin Schmidt,Nicole Look-Hong,Ugwuji N. Maduekwe,Kevin Chang,Theodore S. Hong,Eunice L. Kwak,Gregory Y. Lauwers,David W. Rattner,John T. Mullen,Sam S. Yoon.Noncurative Gastrectomy for Gastric Adenocarcinoma Should only be Performed in Highly Selected Patients[J].Annals of Surgical Oncology.2013(11)
  • 6J. Chen,Z. Tang,X. Dong,S. Gao,H. Fang,D. Wu,D. Xiang,S. Zhang.Radiofrequency ablation for liver metastasis from gastric cancer[J].European Journal of Surgical Oncology.2013(7)
  • 7J.A. Ajani,M. Buyse,M. Lichinitser,V. Gorbunova,G. Bodoky,J.Y. Douillard,S. Cascinu,V. Heinemann,R. Zaucha,A. Carrato,D. Ferry,V. Moiseyenko.Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study[J].European Journal of Cancer.2013
  • 8Florian Lordick,Yoon-Koo Kang,Hyun-Cheol Chung,Pamela Salman,Sang Cheul Oh,Gy?rgy Bodoky,Galina Kurteva,Constantin Volovat,Vladimir M Moiseyenko,Vera Gorbunova,Joon Oh Park,Akira Sawaki,Ilhan Celik,Heiko G?tte,Helena Melezínková,Markus Moehler.Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial[J].Lancet Oncology.2013(6)
  • 9Lei Jiang,Ke‐Hu Yang,Quan‐Lin Guan,Peng Zhao,Yan Chen,Jin‐Hui Tian.Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: A meta‐analysis[J].J Surg Oncol.2013(8)
  • 10Atsushi Nashimoto,Kohei Akazawa,Yoh Isobe,Isao Miyashiro,Hitoshi Katai,Yasuhiro Kodera,Shunichi Tsujitani,Yasuyuki Seto,Hiroshi Furukawa,Ichiro Oda,Hiroyuki Ono,Satoshi Tanabe,Michio Kaminishi.Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry[J].Gastric Cancer.2013(1)

共引文献124

同被引文献8

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部